Discrimination of Traditional Chinese Medicine Syndromes in Type 2 Diabetic Patients Based on Metabolomics-Proteomics Profiles

Table 2

Clinical and biochemical data of the study subjects.

Characteristics	T2DM with non-DHS (n = 30)	T2DM with DHS (n = 30)	value
Age (years)	57.80 ± 11.82	52.97 ± 11.22	0.11
BMI (kg/m^2)	25.92 ± 3.28	26.70 ± 3.65	0.39
FBG (mmol/L)	9.48 ± 3.11	9.82 ± 2.68	0.65
PBG (mmol/L)	14.50 ± 4.12	15.00 ± 4.11	0.64
HbA1c (%)	9.16 ± 1.70	9.42 ± 1.59	0.54
TC (mM)	4.38 ± 1.28	5.57 ± 1.41	≤0.01
TG (mM)	1.58 ± 1.10	3.10 ± 1.79	≤0.01
LDL-C (mM)	2.79 ± 0.83	3.14 ± 1.14	0.18
HDL-C (mM)	1.13 ± 0.22	1.00 ± 0.29	0.06
FCP (pg/mL)	2.02 ± 0.67	2.62 ± 1.11	≤0.01
FINS (pmol/ml)	8.15 ± 5.08	12.24 ± 6.93	≤0.01
HOMA-IR	3.61 ± 3.10	5.44 ± 3.27	0.03

Data were presented as means ± SD, and t-test was applied. The two-tailed value was significant at <0.05. DHS: damp-heat syndrome; BMI: body mass index; FBG: fasting blood glucose; PBG: postprandial plasma glucose; HbA1c: glycosylated hemoglobin; TC: total cholesterol; TG: triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; FCP: fasting c-peptide; FINS: fasting insulin; HOMA-IR: insulin resistance index.